查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632674

全球血液学诊断市场：市场规模、份额、趋势分析（按产品、测试、最终用途和地区）、细分市场预测（2025-2030 年）

Hematology Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test (Blood Count, Platelet Function, Hemoglobin, Hematocrit), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

血液学诊断市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，全球血液诊断市场预计到 2030 年将达到 59.3 亿美元。预计 2025 年至 2030 年的复合年增长率为 6.6%。血液病患病率的不断上升以及自动化检测流程的采用预计将推动市场成长。

血液学诊断过程的自动化可以缩短週转时间，从而加速整体治疗方法。此外，自动化还可以减少管理错误和诊断测试的整体成本。因此，预计未来几年它将推动血液学检测市场的成长。

血液学仪器的优越性得益于客观、高通量、高性价比的全自动分析仪的存在。此外，这些血液学分析仪可以检测异常结果并改善可测量参数，如红血球分布宽度、血小板分布、网状红血球(RET) 计数和有核红血球计数。

即时诊断（PoC）血液学检测设备的出现提高了诊断效果并改善了患者预后。这些设备使用方便，可以在医院外使用。这有望提高血液学检测的可接受性和可近性，从而促进市场成长。

激烈的市场竞争导致产品召回和价格战，预计将阻碍市场成长。 2018 年，碧迪公司 (BD) 召回了其 Vacutainer EDTA 采血管，原因是其会对某些测试产生化学干扰。此次召回被食品药物管理局（FDA）列为 I 级召回，即最严重的召回，显示使用这些设备可能会导致严重伤害甚至死亡。此类产品召回可能会对市场成长产生负面影响。

血液学诊断市场：分析概述

  • 预计消耗品领域将在 2023 年占据 66.0% 的市场份额，占据市场主导地位，预计在预测期内以 6.9% 的最快复合年增长率增长。
  • 血液学部门将在 2024 年占据最大的收益占有率，达到 45.0%。美国癌症协会等组织正在提高人们对导致白血球计数低的疾病和慢性病（如嗜中性白血球低下症）的认识，从而引导人们更频繁地进行白血球检测。
  • 医院部门在 2024 年的收入份额最大，为 41.0%。这是因为刑事鑑定实验室和医院医学实验室对血液诊断的需求不断增长，用于疾病诊断、血球计数测定、非法药物使用检测、治疗药物水平监测、蛋白质分析、血型分型、甲状腺功能评估和抗体存在检测。
  • 2024 年北美血液诊断市场占据主导地位，份额为 45.0%。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章血液学诊断市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 血液学诊断市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章血液学诊断市场：按产品分類的估计和趋势分析

  • 按产品市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球血液检测市场（按产品）展望
  • 市场规模预测及趋势分析（2018-2030年）
    • 装置
    • 耗材

第 5 章血液学诊断市场：按测试类型进行的估计和趋势分析

  • 按测试类型分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球血液检测市场按检测类型展望
  • 市场规模预测及趋势分析（2018-2030年）
    • 血球计数
    • 血小板功能
    • 血红素
    • 血球容积比

第 6 章血液学诊断市场：按最终用途的估计和趋势分析

  • 按最终用途分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球血液学检测市场前景（按最终用途）
  • 市场规模预测及趋势分析（2018-2030年）
    • 医院
    • 诊断实验室
    • 其他的

第 7 章血液学诊断市场：按地区分類的估计和趋势分析

  • 各地区市场占有率（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业市场占有率分析（2023年）
    • Abbott
    • Beckman coulter Inc,
    • Sysmex Corporation
    • F. Hoffman-La Roche Ltd.
    • Siemens Healthineers
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Nihon Kohden Corporation
    • Bio-Rad laboratories
    • Horiba Medical
    • EKF Diagnostics
Product Code: GVR-2-68038-660-8

Hematology Diagnostics Market Growth & Trends:

The global hematology diagnostics market size is expected to reach USD 5.93 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.6% from 2025 to 2030. Increasing prevalence of blood disorders coupled with adoption of automated testing processes are projected to propel the market growth.

Automation of hematology diagnostics process have led to reduced turnaround time thereby accelerating the overall treatment regimen. Furthermore, automation has also led to reduced administrative errors and overall costs of diagnostic tests. Thus, it is expected to boost growth of the hematology testing market in the forthcoming years.

Dominance of hematology analyzers can be attributed to the presence of fully-automated analyzers which are objective, have high-throughput, and are cost-effective. Furthermore, these hematology analyzers can also detect atypical results and can improve measurable parameters such as red cell distribution width, platelet distribution, Reticulocyte (RET) counts, and nucleated red cells counts.

The advent of Point-Of-Care (PoC) hematology testing devices has led to improved diagnostic and patient outcomes. These devices are user-friendly and are available for use outside the hospital settings. This is anticipated to increase the acceptability and accessibility of hematology testing which, in turn, is anticipated to propel market growth.

Product recall and intense market competition leading to price wars are anticipated to hinder market growth. In 2018, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes owing to chemical interference with certain tests. This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA), thereby indicating that the use of these devices may cause serious injuries or death. Such product recalls can negatively affect the market growth.

Hematology Diagnostics Market Report Highlights:

  • The consumables segment dominated the market with a share of 66.0% in 2023 and is also expected to witness the fastest growth with a CAGR of 6.9% in the forecast period.
  • The blood count segment captured the largest revenue share at 45.0 % in 2024. Organizations such as the American Cancer Society are rising awareness about diseases and chronic conditions such as Neutropenia, which are caused low WBC counts, propelling the population towards having frequent WBCs test.
  • The hospital segment held the largest revenue share of 41.0% in 2024. This is attributable to growing hematology diagnostics demand in forensic labs and hospital medical labs for disease diagnosis, blood cell counts, detecting illegal drug use, monitoring therapeutic drug levels, protein analysis, blood typing, thyroid function assessment, and detecting the presence of antibodies.
  • North America hematology diagnostics market dominated the market and accounted for a 45.0 % share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Test type outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hematology Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of blood cancer
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising point-of-care (POC) hematological tests
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. High cost of product
  • 3.3. Hematology Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Hematology Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Hematology Testing Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Instrument
      • 4.4.1.1. Instrument Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Analyzers
        • 4.4.1.2.1. Analyzers Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Flow cytometers
        • 4.4.1.3.1. Flow cytometers Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Others
        • 4.4.1.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Consumables
      • 4.4.2.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Reagents
        • 4.4.2.2.1. Reagents Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Strains
        • 4.4.2.3.1. Strains Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Others
        • 4.4.2.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hematology Diagnostics Market: Test type Estimates & Trend Analysis

  • 5.1. Test type Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Hematology Testing Market by Test type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Blood count
      • 5.4.1.1. Blood count Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Platelet function
      • 5.4.2.1. Platelet function Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Hemoglobin
      • 5.4.3.1. Hemoglobin Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Hematocrit
      • 5.4.4.1. Hematocrit Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hematology Diagnostics Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Hematology Testing Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Diagnostic labs
      • 6.4.2.1. Diagnostic labs Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Hematology Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Beckman coulter Inc,
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Sysmex Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. F. Hoffman-La Roche Ltd.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthineers
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Nihon Kohden Corporation
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Bio-Rad laboratories
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Horiba Medical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. EKF Diagnostics
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 5 Global hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 9 North America hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 12 U.S. hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 15 Canada hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Mexico hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 18 Mexico hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Europe hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 22 Europe hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Germany hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 25 Germany hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 U.K. hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 27 U.K. hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 28 U.K. hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 France hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 30 France hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 31 France hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Italy hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 34 Italy hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Spain hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 37 Spain hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 40 Denmark hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Sweden hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 43 Sweden hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Norway hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 46 Norway hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 China hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 52 China hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 53 China hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Japan hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 56 Japan hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 India hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 58 India hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 59 India hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 61 South Korea hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 62 South Korea hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Australia hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 65 Australia hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Thailand hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 68 Thailand hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Latin America hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 72 Latin America hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Brazil hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 75 Brazil hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 78 Argentina hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 85 South Africa hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 91 UAE hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
  • Table 94 Kuwait hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Hematology Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Hematology diagnostics market: market outlook
  • Fig. 16 Hematology diagnostics competitive insights
  • Fig. 17 Parent market outlook
  • Fig. 18 Related/ancillary market outlook.
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Industry value chain analysis
  • Fig. 21 Hematology diagnostics market driver impact
  • Fig. 22 Hematology diagnostics market restraint impact
  • Fig. 23 Hematology diagnostics market strategic initiatives analysis
  • Fig. 24 Hematology diagnostics market: Product movement analysis
  • Fig. 25 Hematology diagnostics market: Product outlook and key takeaways
  • Fig. 26 Instrument market estimates and forecast, 2018 - 2030
  • Fig. 27 Analyzers market estimates and forecast, 2018 - 2030
  • Fig. 28 Flow cytometers market estimates and forecast, 2018 - 2030
  • Fig. 29 Others market estimates and forecast, 2018 - 2030
  • Fig. 30 Consumables market estimates and forecast, 2018 - 2030
  • Fig. 31 Hematology diagnostics market: Test type movement analysis
  • Fig. 32 Hematology diagnostics market: Test type outlook and key takeaways
  • Fig. 33 Blood count market estimates and forecasts, 2018 - 2030
  • Fig. 34 Platelet function market estimates and forecasts,2018 - 2030
  • Fig. 35 Hemoglobin market estimates and forecasts, 2018 - 2030
  • Fig. 36 Hematocrit market estimates and forecasts,2018 - 2030
  • Fig. 37 Hematology diagnostics market: end-use movement analysis
  • Fig. 38 Hematology diagnostics market: end-use outlook and key takeaways
  • Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 40 Diagnostics labs market estimates and forecasts,2018 - 2030
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030
  • Fig. 42 Global Hematology diagnostics market: Regional movement analysis
  • Fig. 43 Global Hematology diagnostics market: Regional outlook and key takeaways
  • Fig. 44 Global Hematology diagnostics market share and leading players
  • Fig. 45 North America market share and leading players
  • Fig. 46 North America: SWOT
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Europe: SWOT
  • Fig. 49 Asia Pacific market share and leading players
  • Fig. 50 Asia Pacific: SWOT
  • Fig. 51 Latin America market share and leading players
  • Fig. 52 Latin America: SWOT
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 Middle East & Africa: SWOT
  • Fig. 55 North America, by country
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecasts, 2018 - 2030
  • Fig. 58 U.S.
  • Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 60 Canada
  • Fig. 61 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecasts, 2018 - 2030
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 68 France
  • Fig. 69 France market estimates and forecasts, 2018 - 2030
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 76 Sweden
  • Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 82 China
  • Fig. 83 China market estimates and forecasts, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 86 India
  • Fig. 87 India market estimates and forecasts, 2018 - 2030
  • Fig. 88 Thailand
  • Fig. 89 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 92 Australia
  • Fig. 93 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 104 South Africa
  • Fig. 105 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 108 UAE
  • Fig. 109 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 110 Kuwait
  • Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 112 Market share of key market players- Hematology diagnostics market